Vivos Therapeutics (VVOS) Research & Development (2020 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Research & Development of $249000.0 for Q1 2026, down 30.45% year-over-year from $358000.0 in Q1 2025, and down 34.82% quarter-over-quarter from $382000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Research & Development (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Research & Development for 7 consecutive years, with $249000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development fell 30.45% year-over-year to $249000.0; the TTM figure through Mar 2026 stood at $1.3 million (down 9.89% YoY), while the FY2025 annual figure was $1.4 million, down 19.12% from the prior year.
- Research & Development slipped to $249000.0 in Q1 2026 per VVOS's latest filing, from $382000.0 in the prior quarter.
- Across five years, Research & Development topped out at $1.7 million in Q2 2022 and bottomed at $249000.0 in Q1 2026.
- Historically, Research & Development has averaged $633235.3 across 5 years, with a median of $590000.0 in 2023.
- Annual changes were most pronounced in 2022 — Research & Development advanced 21.53% — and 2023, when it plunged 65.27%.
- Vivos Therapeutics' Research & Development stood at $1.4 million in 2022, then tumbled by 55.28% to $606000.0 in 2023, then plunged by 32.01% to $412000.0 in 2024, then decreased by 7.28% to $382000.0 in 2025, then plunged by 34.82% to $249000.0 in 2026.
- Business Quant data shows VVOS's Research & Development at $249000.0 in Q1 2026, $382000.0 in Q4 2025, and $403000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Vivos Therapeutics | 4.97 Mn | 3.17 Mn | 2.95 Mn | 155,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 249,000.00 |
| Dec 31, 2025 | 382,000.00 |
| Sep 30, 2025 | 403,000.00 |
| Jun 30, 2025 | 260,000.00 |
| Mar 31, 2025 | 358,000.00 |
| Dec 31, 2024 | 412,000.00 |
| Sep 30, 2024 | 346,000.00 |
| Jun 30, 2024 | 320,000.00 |
| Mar 31, 2024 | 655,000.00 |
| Dec 31, 2023 | 606,000.00 |
| Sep 30, 2023 | 641,000.00 |
| Jun 30, 2023 | 590,000.00 |
| Mar 31, 2023 | 630,000.00 |
| Dec 31, 2022 | 1.36 Mn |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 1.70 Mn |
| Mar 31, 2022 | 753,000.00 |
| Dec 31, 2021 | 1.32 Mn |
| Sep 30, 2021 | 1.98 Mn |
| Jun 30, 2021 | 1.40 Mn |